UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Molecular cancer, ISSN 1476-4598, 12/2015, Volume 14, Issue 1, pp. 207 - 207
DLBCL | ABC-DLBCL | DTX3L | STAT1 | CAR-T cells | Chemoresistance | STAT3 | PARP | GCB-DLBCL | Antibody drug conjugate | BCR | NF-ΚB | Macrodomain | ADP-ribosylation | ARTD | Biochemistry & Molecular Biology | Oncology | Life Sciences & Biomedicine | Science & Technology | Animals | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Immunotherapy | Neoplasm Recurrence, Local - drug therapy | Drug Resistance, Neoplasm | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Precision Medicine | Phosphates | Ubiquitin | Biological products | Genes | Mortality | Development and progression | Non-Hodgkin's lymphomas | B cells | Transforming growth factors | Gene expression | T cells | Chemotherapy | Ligases | Health aspects | Cancer | Index Medicus
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 12/2005, Volume 25, Issue 23, pp. 10379 - 10390
Journal Article
Oncotarget, ISSN 1949-2553, 04/2016, Volume 7, Issue 17, pp. 23106 - 23127
Sphingolipid | Sphingosine kinase | Fingolimod | FTY720 | Cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Animals | Prognosis | Signal Transduction - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Fingolimod Hydrochloride - therapeutic use | Neoplasms - drug therapy | Index Medicus
Journal Article